Scientists track radioactive tracer in first human test for cancer imaging
NCT ID NCT06463782
Summary
This early-stage study tested a new radioactive tracer called 68Ga-LNC1007, which is used for PET scans to detect cancer. It involved 8 total participants, including both healthy adults and people with solid tumors, to see if the injection was safe and to measure how it traveled through and left the body. The main goal was to gather initial safety data and understand how the tracer behaves, not to treat the cancer itself.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Imaging Research Centre (CIRC) ；National University of Singapore.
Singapore, Singapore
Conditions
Explore the condition pages connected to this study.